Discontinuation Patterns and Cost Avoidance of a Pharmacist-Driven Methicillin-Resistant Staphylococcus aureus Nasal Polymerase Chain Reaction Testing Protocol for De-escalation of Empiric Vancomycin for Suspected Pneumonia
Author(s) -
Lina Meng,
Samaneh Pourali,
Matthew M. Hitchcock,
David Ha,
Emily Mui,
William Alegria,
Emily M. Fox,
Calvin Diep,
Rebecca Swayngim,
Amy Chang,
Niaz Banaei,
Stan Deresinski,
Marisa Holubar
Publication year - 2021
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofab099
Subject(s) - medicine , discontinuation , vancomycin , de escalation , methicillin resistant staphylococcus aureus , staphylococcus aureus , pharmacist , concordance , pneumonia , pharmacy , family medicine , bacteria , biology , genetics
A pharmacist-driven methicillin-resistant Staphylococcus aureus (MRSA) nasal polymerase chain reaction (PCR)-based testing protocol with a 70% acceptance rate for vancomycin discontinuation within 24 hours of negative results significantly reduced unnecessary vancomycin use with an estimated cost avoidance of $40 per vancomycin course. We found high concordance (141 of 147, 96%) of culture-based versus PCR-based MRSA nasal screening.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom